Sichenzia Ross Ference LLP Represents Rodman & Renshaw a Unit of H.C Wainwright in a $15 Million Upsized Public Offering of Medical Transcript Billing, Corp.
Press Release – New York, NY – October 15, 2018 – Sichenzia Ross Ference LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (MTBC.NASDAQ).
MTBC is a principal provider of proprietary, cloud-based electronic health records, practice management, and mHealth solutions. MTBC received approximately $15 million in gross proceeds from the sale of 600,000 shares of Series A Preferred Stock sold to the public at a price of $25 per share for an aggregate offering amount of $15 Million. The series A Preferred Stock is traded on NASDAQ under the symbol “MTBCA.” The offering is expected to close on or around October 15 2018, subject to the satisfaction of customary closing conditions.
The Sichenzia Ross Ference LLP team was led by partners Gregory Sichenzia, Tom Rose and Jay Yamamoto.
Visit SRF's LinkedIn page
Latest posts by Sichenzia Ross Ference LLP (see all)
- Sichenzia Ross Ference LLP Represents Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) in Offering of $1.2 Million American Depositary Shares - May 24, 2019
- Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $8.0 Million Public Offering of Common Stock of Medalist Diversified REIT, Inc. - May 14, 2019
- Founding Partner Gregory Sichenzia to Moderate Cannabis Investor Panel - May 10, 2019